Agency overview | |
---|---|
Formed | December, 2006 |
Headquarters | Hubert H. Humphrey Building Washington, D.C. |
Agency executive |
|
Parent agency | United States Department of Health and Human Services |
Website | Office of the Assistant Secretary for Preparedness and Response |
The Office of the Assistant Secretary for Preparedness and Response (ASPR) within the United States Department of Health and Human Services that focuses on preparedness planning and response; building federal emergency medical operational capabilities; countermeasures research, advance development, and procurement; and grants to strengthen the capabilities of hospitals and health care systems in public health emergencies and medical disasters. The office provides federal support, including medical professionals through ASPR’s National Disaster Medical System, to augment state and local capabilities during an emergency or disaster.
The Office was previously the Office of Public Health Emergency Preparedness (OPHEP), which was created in 2002. In 2006, the Pandemic and All Hazards Preparedness Act created ASPR in its current form in the wake of Hurricane Katrina to lead the nation in preventing, preparing for, and responding to the adverse health effects of public health emergencies and disasters.
In July 2022, it was announced that the agency was being elevated from a staff office to an operating division, and renamed the Administration of Strategic Preparedness and Response. [1]
Under the Pandemic and All Hazards Preparedness Act of 2006 (PAHPA), Public Law No. 109-417, HHS is the lead agency for the National Response Framework (NRF) for Emergency Support Function 8 (ESF-8). The Secretary of HHS delegates to ASPR the leadership role for all health and medical services support functions in a health emergency or public health event. To meet the public information requirements of PAHPA the Public Health Emergency.gov web portal was created to serve as a single point of access to public health risk, and situational awareness information when the President or the Secretary of Health and Human Services exercise their public health emergency legal authority.
The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress) Pub.L. 113–5 (text) (PDF) improved and reauthorized the provisions of the PAHPA. [2] The primary portion of the bill dealing with this office is Section 102. Among other things, the bill requires the Assistant Secretary for Preparedness and Response, with respect to overseeing advanced research, development, and procurement of qualified countermeasures, security countermeasures, and qualified pandemic or epidemic products, to: [2]
The ASPR is the Secretary's principal advisor on matters related to bioterrorism and other public health emergencies. They are responsible for coordinating interagency activities between HHS, other Federal departments, agencies, offices and State and local officials responsible for emergency preparedness and the protection of the civilian population from acts of bioterrorism and other public health emergencies. The ASPR also works closely with global partners to address common threats around the world, enhancing national capacities to detect and respond to such threats, and to learn from each other’s experiences as another step toward national health security for the United States and other countries. [6]
The United States National Response Framework (NRF) is part of the National Strategy for Homeland Security that presents the guiding principles enabling all levels of domestic response partners to prepare for and provide a unified national response to disasters and emergencies. Building on the existing National Incident Management System (NIMS) as well as Incident Command System (ICS) standardization, the NRF's coordinating structures are always in effect for implementation at any level and at any time for local, state, and national emergency or disaster response.
The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is an interagency coordinating body lead by the ASPR. It coordinates the development, acquisition, stockpiling, and recommendations for using medical countermeasures to deal with public health emergencies. [7] Along with Biomedical Advanced Research and Development Authority (BARDA), it includes internal HHS partners at the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC), along with external inter-agency partners at the Department of Defense (DoD), the United States Department of Homeland Security (DHS), the United States Department of Agriculture (USDA), and the United States Department of Veterans Affairs (VA).
In July 2019, the Blue Ribbon Study Panel on Biodefense announced a new idea to improve U.S. national security against bioterrorism: a "Manhattan Project for Biodefense." The idea is a "proposed national, public-private research and development undertaking that would defend the United States against biological threats" and is publicly supported by retired U.S. Senator Joseph Lieberman, the co-chair of the panel, and Robert Kadlec, former U.S. Assistant Secretary for Preparedness and Response. Kadlec remarked, “We highly endorse such an endeavor in the sense of it’s time to say, ‘Go big or go home’ on this issue." [8]
The Office of Public Health Emergency Preparedness was established in June 2002 at the request of Tommy Thompson.
Its scope of activity included preparedness for bioterrorism, chemical and nuclear attack, mass evacuation and decontamination. [9]
The first head of OPHEP was Donald Henderson, credited with having previously eradicated Smallpox. Soon Jerry Hauer, a veteran public health expert, took over as director, with Henderson taking a different role in the department. Hauer was removed from the job primarily for conflicts he had with Scooter Libby over whether the risks of smallpox vaccination were worth the benefit. Hauer charged that the Office of the Vice President was pushing for the universal vaccination despite the vaccine's health risks, primarily exaggerate the risk of biological terrorism.
In July 2006, a bill to amend the Public Health Service Act with respect to public health security and all-hazards preparedness and response was introduced. On December 19, 2006 it became public law and OPHEP was officially changed to the Office of the Assistant Secretary for Preparedness and Response.
RADM W. Craig Vanderwagen, M.D., was sworn into office on March 27, 2007 as the first Assistant Secretary for Preparedness and Response and recently retired.
RADM Nicole Lurie, MD, MSPH served as the ASPR until January 20, 2017. Dr. George Korch currently serves as the Acting Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services
Biodefense refers to measures to restore biosecurity to a group of organisms who are, or may be, subject to biological threats or infectious diseases. Biodefense is frequently discussed in the context of biowar or bioterrorism, and is generally considered a military or emergency response term.
The United States Department of Health and Human Services (HHS), is a cabinet-level executive branch department of the U.S. federal government created to protect the health of all Americans and providing essential human services. Its motto is "Improving the health, safety, and well-being of America". Before the separate federal Department of Education was created in 1979, it was called the Department of Health, Education, and Welfare (HEW).
The Strategic National Stockpile (SNS), originally called the National Pharmaceutical Stockpile (NPS), is the United States' national repository of antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies. Its website states:
"The Strategic National Stockpile's role is to supplement state and local supplies during public health emergencies. Many states have products stockpiled, as well. The supplies, medicines, and devices for life-saving care contained in the stockpile can be used as a short-term stopgap buffer when the immediate supply of adequate amounts of these materials may not be immediately available."
The Biodefense and Pandemic Vaccine and Drug Development Act of 2005, nicknamed "Bioshield Two" and sponsored by Senator Richard Burr, aims to shorten the pharmaceutical development process for new vaccines and drugs in case of a pandemic, and to protect vaccine makers and the pharmaceutical industry from legal liability for vaccine injuries. The proposed bill would create a new federal agency, the Biomedical Advanced Research and Development Agency (BARDA), that would act "as the single point of authority" to promote advanced research and development of drugs and vaccines in response to bioterrorism and natural disease outbreaks, while shielding the agency from public Freedom of Information Act (FOIA) requests. BARDA would be exempt from long-standing open records and meetings laws that apply to most government departments.
The National Disaster Medical System (NDMS) is a federally coordinated healthcare system and partnership of the United States Departments of Health and Human Services (HHS), Homeland Security (DHS), Defense (DOD), and Veterans Affairs (VA). The purpose of the NDMS is to support State, local, Tribal and Territorial authorities following disasters and emergencies by supplementing health and medical systems and response capabilities. NDMS would also support the military and the Department of Veterans Affairs health care systems in caring for combat casualties, should requirements exceed their capacity.
Rear Admiral W. Craig Vanderwagen USPHS - retired is a Founder and General Manager of East West Protection, LLC. EWP provides disaster preparedness policy and program development, management, strategic planning advice, training management, and threat and impact studies and analytical support to local, national and international organizations in both the public and private sectors.
Signed into effect on 12 June 2002, the Public Health Security and Bioterrorism Preparedness and Response Act, (PHSBPRA) was signed by the President, the Department of Health and Human Services (DHHS) and the U.S. Department of Agriculture (USDA).
The Johns Hopkins Center for Health Security is an independent, nonprofit organization of the Johns Hopkins Bloomberg School of Public Health. The Center works to protect people’s health from epidemics and pandemics and ensures that communities are resilient to major challenges. The Center is also concerned with biological weapons and the biosecurity implications of emerging biotechnology.
The Project Bioshield Act was an act passed by the United States Congress in 2004 calling for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack. This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines which had not been tested for safety or efficacy in humans, due to ethical concerns. Efficacy of such agents cannot be directly tested in humans without also exposing humans to the chemical, biological, or radioactive threat being treated, so testing follows the FDA Animal Rule for pivotal animal efficacy.
The Biomedical Advanced Research and Development Authority(BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
On December 19, 2006, the Pandemic and All-Hazards Preparedness Act (PAHPA), Public Law No. 109-417, was signed into law by President George W. Bush. First introduced in the House by Rep. Mike Rogers (R-MI) and Rep. Anna Eshoo (D-CA), PAHPA had broad implications for the United States Department of Health and Human Services's (HHS) preparedness and response activities. Among other things, the act amended the Public Health Service Act to establish within the department a new Assistant Secretary for Preparedness and Response (ASPR); provided new authorities for a number of programs, including the advanced development and acquisitions of medical countermeasures; and called for the establishment of a quadrennial National Health Security Strategy.
PublicHealthEmergency.gov is a web portal created by the U.S. Department of Health and Human Services to serve as a single point of entry for access to public health risk, and situational awareness information when the President or the Secretary of Health and Human Services exercise their public health emergency legal authority. This site acts as a portal for residents in the U.S. and worldwide to obtain information from all U.S. federal agencies involved in a public health emergency, a medical disaster or the public health aspects of a natural or man-made disaster.
Nicole Lurie is an American physician, professor of medicine, and public health official. During the administration of President Barack Obama, she was Assistant Secretary for Preparedness and Response (ASPR) at the United States Department of Health and Human Services (HHS) from 2009 through the end of the president's second term. The mission of the Office of the Assistant Secretary for Preparedness and Response is to "lead the nation in preventing, responding to and recovering from the adverse health effects of public health emergencies and disasters, ranging from hurricanes to bioterrorism."
Biosecurity in the United States is governed by the Bureau of Western Hemisphere Affairs, which is part of the US Department of State. It obtains guidance and advice on specific matters relating to biosecurity from various other government agencies.
The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 is a law enacted by the 113th United States Congress. The Act amends the Public Health Service Act in order to extend, fund, and improve several programs designed to prepare the United States and health professionals in the event of a pandemic, epidemic, or biological, chemical, radiological, or nuclear accident or attack. The Act clarifies the authority of different American officials, makes it easier to temporarily reassign personnel to respond to emergency situations, and alters the process for testing and producing medical countermeasures. The Act is focused on improving preparedness for any public health emergency.
The Bipartisan Commission on Biodefense, formerly known as the Blue Ribbon Study Panel on Biodefense, is an organization of former high-ranking government officials that analyzes US capabilities and capacity to defend against biological threats. According to the Commission's mission statement, the organization was formed to "provide for a comprehensive assessment of the state of U.S. biodefense efforts, and to issue recommendations that will foster change."
The Strengthening Public Health Emergency Response Act of 2015, H.R. 3299, is a bill introduced in the U.S. House of Representatives that would streamline government decisions and provide incentives for vaccines and treatment of dangerous pathogens and diseases. The bill was introduced by Representatives Susan Brooks (R-IN) and Anna Eshoo (D-CA).
The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases. It is headquartered in Washington DC.
Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services from August 2017 until January 2021.
The Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) is legislation introduced and passed by the U.S. Congress in 2019 that aims to improve the nation's preparation and response to public health threats, including both natural threats and deliberate man-made threats.
This article incorporates public domain material from websites or documents ofthe United States Government .